drugset

drugset / Trial / NCT00212654

Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan

NCT00212654 ↗

Phase 2/3 Completed 165 enrolled Ono Pharmaceutical Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in postoperative supraventricular tachyarrhythmias.

Timeline

Start: 2001-06
Primary completion: 2006-04
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Landiolol	Small molecule	—	—

Indications